Search Results - "Escamez, M J"
-
1
Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer‐prone genodermatoses
Published in British journal of dermatology (1951) (01-09-2019)“…Summary Background Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three…”
Get full text
Journal Article -
2
The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation
Published in British journal of dermatology (1951) (01-07-2010)“…Summary Background Dystrophic epidermolysis bullosa (DEB) is a genodermatosis caused by mutations in COL7A1. The clinical manifestations are highly variable…”
Get full text
Journal Article -
3
Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex
Published in British journal of dermatology (1951) (01-09-2011)“…Summary Background Basal epidermolysis bullosa simplex (EBS) is a group of blistering genodermatoses mostly caused by mutations in the keratin genes, KRT5 and…”
Get full text
Journal Article -
4
Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa
Published in British journal of dermatology (1951) (01-03-2020)“…Linked Comment: Uitto. Br J Dermatol 2020; 182:526–527. Plain language summary available online…”
Get full text
Journal Article -
5
A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa
Published in Dermatology (Basel) (01-12-2011)Get more information
Journal Article -
6
Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis
Published in Matrix biology (01-08-2022)“…•Severe fibrotic features in recessive dystrophic epidermolysis bullosa (RDEB) are favored by a pro-oxidant status and hyper-responsiveness to TGF-β of dermal…”
Get full text
Journal Article -
7
Genetic diagnosis of epidermolysis bullosa: recommendations from an expert Spanish research group
Published in Actas dermo-sifiliográficas (English ed.) (01-03-2018)Get full text
Journal Article -
8
Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years’ experience of a reference centre in Spain
Published in Clinical & translational oncology (01-11-2019)“…Background Cutaneous squamous cell carcinoma (cSCC) is the leading cause of death in patients with recessive dystrophic epidermolysis bullosa (RDEB). We…”
Get full text
Journal Article -
9
Recessive dystrophic epidermolysis bullosa: the origin of the c.6527insC mutation in the Spanish population
Published in British journal of dermatology (1951) (01-01-2013)Get full text
Journal Article -
10
Novel human pathological mutations. Gene symbol: COL7A1. Disease: Epidermolysis bullosa dystrophica
Published in Human genetics (01-08-2009)Get full text
Journal Article -
11
Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care
Published in Actas dermo-sifiliográficas (English ed.) (01-12-2013)“…Dystrophic epidermolysis bullosa (DEB) is a rare disease that represents a heavy burden for both the patient and the health care system. There are currently no…”
Get full text
Journal Article -
12
Novel human pathological mutations. Gene symbol: COL7A1. Disease: Epidermolysis bullosa dystrophica
Published in Human genetics (01-01-2010)Get full text
Journal Article -
13
Novel human pathological mutations. Gene symbol: COL7A1. Disease: Epidermolysis bullosa dystrophica
Published in Human genetics (01-01-2010)Get full text
Journal Article -
14
X-linked ichthyosis along with recessive dystrophic epidermolysis bullosa in the same patient
Published in Dermatology (Basel) (01-01-2010)“…X-linked ichthyosis (XLI) is a relatively common keratinization disorder which is caused, in the vast majority of cases, by a total deletion of the sulfatase…”
Get more information
Journal Article -
15
Epidermolysis Bullosa in Spain: Observational Study of a Cohort of Patients Treated in a National Referral Center
Published in Actas dermo-sifiliográficas (English ed.) (01-10-2021)“…BACKGROUND AND OBJECTIVEEpidermolysis bullosa (EB) is a heterogeneous group of inherited disorders characterized by a high degree of mucocutaneous fragility…”
Get full text
Journal Article -
16
Type 3 iodothyronine deiodinase is selectively expressed in areas related to sexual differentiation in the newborn rat brain
Published in Endocrinology (Philadelphia) (01-11-1999)“…Thyroid hormone (T4 and T3) concentrations in target tissues are greatly influenced by the activity of iodothyronine deiodinases. Type 1 and 2 deiodinases…”
Get full text
Journal Article -
17
Skin gene therapy for acquired and inherited disorders
Published in Histology and histopathology (01-11-2006)“…The rapid advances associated with the Human Genome Project combined with the development of proteomics technology set the bases to face the challenge of human…”
Get full text
Journal Article -
18
Expression of Type 2 Iodothyronine Deiodinase in Hypothyroid Rat Brain Indicates an Important Role of Thyroid Hormone in the Development of Specific Primary Sensory Systems
Published in The Journal of neuroscience (01-05-1999)“…Thyroid hormone is an important epigenetic factor in brain development, acting by modulating rates of gene expression. The active form of thyroid hormone,…”
Get full text
Journal Article -
19
Novel human pathological mutations. Gene symbol: COL7A1. Disease: Epidermolysis Bullosa, Distrophic
Published in Human genetics (01-01-2010)Get full text
Journal Article -
20
Transcriptional induction of RC3/neurogranin by thyroid hormone: differential neuronal sensitivity is not correlated with thyroid hormone receptor distribution in the brain
Published in Brain research. Molecular brain research. (03-10-1997)“…RC3/neurogranin is a calmodulin-binding protein kinase C substrate, located in dendritic spines of forebrain neurons. It has been implicated in post-synaptic…”
Get full text
Journal Article